Health and Human Services Department Grant: Advancing Toxicity Assays for Organ Health

Opportunity ID: 44976

General Information

Document Type: Grants Notice
Funding Opportunity Number: PA-09-007
Funding Opportunity Title: Innovative Toxicity Assays of Pollutants, Therapeutics, and Drugs (STTR [R41/R42])
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Environment
Food and Nutrition
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.113 — Environmental Health
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Jan 26, 2009
Last Updated Date:
Original Closing Date for Applications: Sep 07, 2009
Current Closing Date for Applications: Sep 07, 2009
Archive Date: Oct 08, 2009
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Small businesses
Additional Information on Eligibility:

Additional Information

Agency Name: National Institutes of Health
Description: -Purpose. This Funding Opportunity Announcement (FOA) encourages Small Business Technology Transfer (STTR) grant applications from small business concerns (SBCs) that propose to develop, standardize, and validate new and innovative assays, integrated strategies, or batteries of assays that determine or predict specific organ toxicities (e.g., ocular, dermal, hematotoxicity, cardiotoxicity, gastrointestinal toxicity, hepatotoxicity, nephrotoxicity, ototoxicity, olfactory loss, bladder toxicity, neurotoxicity, pulmonary toxicity, endocrine toxicity, and pancreatic beta cell toxicity), resulting from both acute and chronic exposures to various chemicals, environmental pollutants, biologics and therapeutic molecules or drugs. In addition, this FOA encourages the development, standardization, and validation of new models of arthritis, convulsion, infection and shock. New approaches for high throughput toxicity screening that involves the use of molecular endpoints, computer modeling, proteomics, genomics and epigenomics and the development of virtual tissues are also encouraged as are development of 3-dimensional organ models for toxicity evaluation.
-Mechanism of Support. This FOA will utilize the STTR (R41/R42) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-09-006, that encourages applications under the Small Business Innovation Research (SBIR) (R43/R44) grant mechanisms.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PA-09-007.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email: FBOWebmaster@OD.NIH.GOV

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
ADOBE-FORMS-A Adobe-Forms-A PKG00010186 Jan 26, 2009 Sep 07, 2009 View

Package 1

Mandatory forms

44976 RR_SF424-1.1.pdf

44976 RR_KeyPersonExpanded-1.1.pdf

44976 RR_OtherProjectInfo-1.1.pdf

44976 RR_PerformanceSite-1.1.pdf

44976 RR_Budget-1.1.pdf

44976 RR_SubawardBudget-1.2.pdf

44976 SBIR_STTR_Information-1.0.pdf

44976 PHS398_CoverPageSupplement-1.1.pdf

44976 PHS398_ResearchPlan-1.1.pdf

44976 PHS398_Checklist-1.1.pdf

Optional forms

44976 PHS398_CoverLetter-1.1.pdf


Comments

Leave a Reply

Your email address will not be published. Required fields are marked *